People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EpiVax Therapeutics, Inc. | — | Biotechnology | Seed | $2.6M | $14.8M | 2017 |
| Mabcure Inc. | — | Biotechnology | Pre-Seed | $315K | $17.4M | 2011 |
Gad Berdugo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gad Berdugo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Frank | 1 | 4 |
| Daniel Adams | 1 | 4 |
| William Martin | 1 | 3 |
| Richard Lipkin | 1 | 2 |
| Ron Kalfus | 1 | 1 |
| Clifford Grimm | 1 | 1 |
| Anne De Groot | 1 | 1 |
| Amnon Gonenne | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.